Synthesis of 2-chloro-4-(3-nitrophenoxy)-6-(thiophen-2-yl) pyrimidine

Jianlan Kou; Feiyi Yang

doi:10.54097/hset.v2i.560

Authors

Jianlan Kou
Feiyi Yang

DOI:

https://doi.org/10.54097/hset.v2i.560

Keywords:

2-Chloro-4-(3-nitrophenoxy)-6-(thiophen-2-yl) pyrimidine, Synthesis

Abstract

2-Chloro-4-(3-nitrophenoxy)-6-(thiophen-2-yl) pyrimidine (c) is an important intermediate of small molecule anticancer drugs. In this paper, a rapid synthesis method for the target compound has been developed. Compound c was synthesized from 2,4,6-trichloropyrimidine (a) through two steps including nucleophilic substitution and coupling reaction. The structure of the target compound c was confirmed by 1H NMR and MS spectrum. Furthermore, the synthetic method was optimized. The total yield of the two steps was up to 44.6%.

Downloads

Download data is not yet available.

References

L. Osmani, F. Askin, E. Gabrielson, Q.K. Li, other, 52 (2018).

C. Luo, J.S. Bandar, J. Am. Chem. Soc. 141, 14120 (2019).

Z. Cai, Q. Liu, Sci. China Life Sci. 64, 1017 (2019).

A.A. Goizueta, R.M. Estrada-Y-Martin, S.V. Cherian, Current Pulmonology Reports, 15 (2021).

R. L. Siegel, K. D. Miller, H. E. Fuchs, A. Jemal, Cancer statistics, 71, 1 (2021).

Z. Yang, N. Yang, Q. Ou, Y. Xiang, T. Jiang, X. Wu, H. Bao, X. Tong, X. Wang, Y. W. Shao, Y. Liu, Y. Wang, C. Zhou, clincanres, 24, 3097 (2018).

C. J Lord, A. Ashworth, Nat. Med., 19, 1381(2013).

P. Blume-Jensen, T. Hunter, Nature, 411, 355 (2001).

M. A. Olayioye, R. M. Neve, H. A. Lane, N.E. Hynes, John Wiley & Sons, Ltd. 19, 3159 (2000).

A. Ullrich，L. Coussens，J.S. Hayflick，T.J. Dull, A. Gray, A.W. Tam, J. Lee, Y. Yarden, T.A. Libermann, J. Schlessinger, J. Downward, E.L.V. Mayes, N. Whittle, M.D. Waterfield, P.H. Seeburg, Nature, 309, 418 (1984).

B. R. Voldborg, L. Damstrup, M. Spang-Thomsen, H. S. Poulsen, Ann. Oncol., 8, 1197 (1997).

C. Panosa, F. Tebar, M. FerrerBatalle, H. Fonge, M. Seno, R. M. Reilly, A. Massaguer, R. D. Llorens, Plos One, 8, 670 (2013).

F. Janku, D. J. Stewart, R. Kurzrock, Nat. Rev. Clin. Oncol., 7, 401 (2010).

S.V. Sharma, J. Settleman, D.W. Bell, D.A. Haber, Nat. Rev. Cancer,7, 169 (2007).

M. A. Lemmon, J. Schlessinger, Cell, 141, 1117 (2010).

T. Gazori, I. Haririan, S. Fouladdel, A. Namazi, A. Nomani, E. Azizi, Carbohydr. Polym., 80, 1042 (2010).

C. Yewale, D. Baradia, I. Vhora, A. Misra, Expert. Opin. Drug. Deliv., 10, 1429 (2013).

R. T. Dungo, G. M. Keating, Drugs, 73, 1503 (2013).

J.A. Engelman, K. Zejnullahu, C.M. Gale, E. Lifshits, A. J. Gonzales, T. Shimamura, F. Zhao, P. W. Vincent, G. N. Naumov, J. E. Bradner, I. W. Althaus, L. Gandhi, G. I. Shapiro, J. M. Nelson, J. V. Heymach, M. Meyerson, K. K. Wong, P. A. Janne, Cancer Res., 67, 11924 (2008).

M. R. V. Finlay, M. Anderton, S. Ashton, P. Ballard, P. A. Bethel, M. R. Box, R. H. Bradbury, S. J. Brown, S. Butterworth, A. Campbell, C. Chorley, N. Colclough, D. A. E. Cross, G. S. Currie, M. Grist, L. Hassall, G. B. Hill, D. James, M. James, P. Kemmitt, T. Klinowska, G. Lamont, S. G. Lamont, N. Martin, H. L. McFarland, M. J. Mellor, J. P. Orme, D. Perkins, P. Perkins, G. Richmond, P. Smith, R. A. Ward, M. J. Waring, D. Whittaker, S. Wells, G. L. Wrigley, J Med Chem, 57, 8249 (2014).

R. T. T. Sjin, K. Lee, A. O. Walter, A. Dubrovskiy, M. Sheets, T. S. Martin, M. T. Labenski, Z. Zhu, R. Tester, R. Karp, A. Medikonda, P. Chaturvedi, Y. Ren, H. Haringsma, J. Etter, M. Raponi, A. D. Simmons, T. C. Harding, D. Niu, M. Nacht, W. F. Westlin, R. C. Petter, A. Allen, J. Singh, Mol. Cancer Ther., 13, 1468 (2014).

E. S. Kim, Drugs, 76, 1153 (2016).

UNIV JIANGXI NORMAL SCI & TECH, CN111732597A, 2020.

X. Hu, S. Tang, F. Yang, P. Zheng, S. Xu, Q. Pan, W. Zhu, Molecules, 26, 3041 (2021).